Cargando…
EGFR-TKI治疗非小细胞肺癌中枢神经系统转移的进展
Approximately half of all patients with non-small cell lung cancer (NSCLC) develop central nervous system metastases during the course of their disease which indicate poor prognosis. A part of NSCLC patients demonstrates activating epidermal growth factor receptor gene (EGFR) mutations who represent...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972986/ https://www.ncbi.nlm.nih.gov/pubmed/27561797 http://dx.doi.org/10.3779/j.issn.1009-3419.2016.08.02 |
Ejemplares similares
-
贝伐珠单抗治疗非小细胞肺癌脑转移的研究进展
Publicado: (2016) -
ALK阳性非小细胞肺癌脑转移患者的治疗
Publicado: (2016) -
非小细胞肺癌脑转移的靶向和免疫治疗
Publicado: (2016) -
非小细胞肺癌脑膜转移的临床病理特征及预后分析
Publicado: (2016) -
非小细胞肺癌脑转移放疗时机的选择及疗效预后分析
Publicado: (2016)